Kathrin Klein
Impact in
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Papers in
- Pharmacology 55
- Pharmacogenetics and Drug Metabolism 55
- Drug-Induced Hepatotoxicity and Protection 9
- Oncology 51
- Drug Transport and Resistance Mechanisms 46
- Co-authors
- Ulrich M. ZangerMatthias SchwabMichel EichelbaumAndreas K. NüsslerOliver BurkMiia TurpeinenElke SchaeffelerStefan Winter
- Journals
- Drug Metabolism and Disposition (11 papers)Clinical Pharmacology & Therapeutics (9 papers)Frontiers in Pharmacology (7 papers)Pharmacogenomics (5 papers)Pharmacogenetics and Genomics (5 papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Kathrin Klein
110 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Pharmacology 3.6k
- Transplantation 346
- Oncology 2.9k
- Virology 353
- Pediatrics, Perinatology and Child Health 1.3k
Countries citing papers authored by Kathrin Klein
This map shows the geographic impact of Kathrin Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Klein more than expected).
Fields of papers citing papers by Kathrin Klein
This network shows the impact of papers produced by Kathrin Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Klein. The network helps show where Kathrin Klein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kathrin Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2019 | 44 | |
| 6 | 2018 | 11 | |
| 7 | 2017 | 33 | |
| 8 | 2015 | 123 | |
| 9 | 2015 | 25 | |
| 10 | 2013 | 8 | |
| 11 | 2013 | 73 | |
| 12 | 2013 | 175 | |
| 13 | 2013 | 44 | |
| 14 | 2012 | 124 | |
| 15 | 2010 | 78 | |
| 16 | 2009 | 7 | |
| 17 | 2009 | 306 | |
| 18 | 2007 | 9 | |
| 19 | 2006 | 171 | |
| 20 | 2003 | 23 |
About Kathrin Klein
Kathrin Klein is a scholar working on Pharmacology, Oncology, Equine, Clinical Biochemistry and Biochemistry, having authored 112 papers that have together received 7.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (55 papers), Drug Transport and Resistance Mechanisms (46 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), HIV/AIDS drug development and treatment (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Hormonal Regulation and Hypertension (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Metabolism and Genetic Disorders (5 papers). The work is most often cited by research in Pharmacology (3.6k citations), Transplantation (346 citations), Oncology (2.9k citations), Virology (353 citations) and Pediatrics, Perinatology and Child Health (1.3k citations). Kathrin Klein has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Ulrich M. Zanger, Matthias Schwab, Michel Eichelbaum, Andreas K. Nüssler, Oliver Burk, Miia Turpeinen, Elke Schaeffeler, Stefan Winter, P. Neuhaus and Thomas Lang. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Frontiers in Pharmacology, Pharmacogenomics and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.